Article
Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.
Journal of neurochemistry - 1 Jun 2010
Gros-Louis Francois, Soucy Geneviève, Larivière Roxanne, Julien Jean-Pierre
Abstract excerpt
The finding of a secretion pathway and toxicity for mutant superoxide dismutase 1 (SOD1) raised up the possibility of using immunization approaches to reduce or neutralize the burden of toxic SOD1 species in the nervous system. Here we tested a passive immunization approach based on intracerebroventricular infusion in G93A-SOD1 mice of monoclonal antibodies specific to misfolded forms of SOD1 (mSOD1). We tested...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
